Sorry for interrupting, this website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Learn more
Accept & Close

Diabetic Health - US - September 2018

"As increasingly more Americans face a diabetes diagnosis, demand is growing for effective, reliable and affordable tools to screen, monitor, and manage diabetes. The disease is complex and often overwhelming, not to mention costly for individuals and society alike. Opportunities are especially ripe for the integration of less invasive monitors, digital sensors and integrated health management platforms that can simplify and streamline care for patients."

– Marissa Gilbert, Associate Director - Health & Wellness

This report examines the following issues:

  • The diabetic market is small, but likely underrepresented
  • Managing diabetes can be costly and overwhelming, notably for type 1 diabetics
  • OTC private label products command growing share of MULO sales

What you get

What's included

Why buy from us?

Succeed

Our reports will provide you with market data, consumer research and competitive intelligence to succeed in your market.

Instant Access

Buy now and you'll have instant access to the information you need to make the right decisions.

Opportunities

Find out what's next in the markets that matter to you: where opportunities lie and what challenges you will face.

Trusted

A business Superbrand, Mintel is a source you can trust. We have been defining and refining the Market Intelligence mix since 1972.

Table of contents

  1. Overview

    • What you need to know
      • Definition
      • Executive Summary

        • Issues
          • The diabetic market is small, but likely underrepresented
            • Figure 1: Diabetes incidence, May 2018
          • Managing diabetes can be costly and overwhelming, notably for type 1 diabetics
            • Figure 2: Barriers to care, by diabetes type, May 2018
          • OTC private label products command growing share of MULO sales
            • Figure 3: Private label share of MULO OTC diabetic product sales, by segment, rolling 52 weeks 2017 and 2018
          • Opportunities
            • Interest in blood glucose monitoring technologies highlights market growth potential
              • Figure 4: Interest in trying finger-stick-free CGMs and closed loop system, by diabetes type, May 2018
            • Support medical intervention along with lifestyle changes
              • Figure 5: Lifestyle management activities, by type of diabetes, May 2018
            • Attitudes support more screening, testing, and preventive measures
              • Figure 6: Select attitudes toward diabetes, May 2018
            • US population shifts emphasize the need for diverse solutions
              • Figure 7: Incidence of type 1 diabetes, type 2 diabetes and prediabetes, by age, race, and Hispanic origin, May 2018
            • What it means
            • The Market – What You Need to Know

              • Diabetes incidence limited; undiagnosed cases could be masking real size of the market
                • Risk factors include obesity and inactivity; certain ages, race/ethnicities also notably impacted
                  • The annual cost of diabetes in the US tops $327 billion
                  • The Diabetic Market

                    • The adult diabetes market is small; undiagnosed cases understate actual size of the market
                      • Figure 8: Diabetes incidence, May 2018
                    • Those with type 2 diabetes skew older, more racially diverse
                      • Figure 9: Demographic profile of those with diabetes or prediabetes, May 2018
                    • Length of time with diabetes
                      • Figure 10: Repertoire of length of time with diabetes, May 2018
                      • Figure 11: Length of time with diabetes, by diabetes type, May 2018
                    • Incidence of gestational diabetes
                      • Figure 12: Gestational diabetes incidence, May 2018
                    • Children and diabetes
                      • Figure 13: Child diabetes incidence, by parents of children under 18, May 2018
                  • Risk Factors for Prediabetes and Type 2 Diabetes

                      • Obesity rates continue to rise in the US
                        • Figure 14: US prevalence of obesity among adults aged 20 and over, by age and race/ Hispanic origin, 2015-16
                      • Inactivity contributes to risk of type 2 diabetes
                        • Aging US population commands attention
                          • Figure 15: US population aged 18+, by age, 2013-23
                        • Non-White adults are at a greater risk for diabetes
                          • Figure 16: US population by race and Hispanic origin, 2013-23
                      • Wider Costs and Secondary Health Issues

                        • Direct and indirect costs of diabetes top $327 billion
                          • Long-term, uncontrolled diabetes can cause major health complications
                          • Key Players – What You Need to Know

                            • Four leaders command 37% share of MULO sales of OTC diabetes care
                              • Private label expands reach, especially in home kits and testing
                                • Glucose monitoring devices lead OTC sales
                                  • CGMs and artificial pancreas offer less-invasive, more efficient care
                                    • Mobile apps, smart meters, and technological solutions on horizon
                                    • Company and Brand Sales of OTC Diabetic Products

                                      • MULO sales offer little insight into the OTC diabetic market
                                        • Figure 17: Multi-outlet sales of OTC diabetic products, by type of product, rolling 52 weeks 2017 and 2018
                                      • Largest four companies show little growth, as private label expands
                                        • Figure 18: Multi-outlet sales of OTC diabetic products, by leading companies, rolling 52 weeks 2017 and 2018
                                    • What’s Working?

                                      • Private label commands half of MULO sales and grows share
                                        • Figure 19: Private label market share of MULO sales of OTC diabetic products, by segment, rolling 52 weeks 2017 and 2018
                                      • Glucose monitoring segment grows over 3%
                                        • CGM without routine finger-stick calibration
                                          • Expanded availability and on-going improvements to artificial pancreas technology
                                            • Innovations in insulin speed
                                              • Mobile apps and smart meters for care and health management
                                              • What’s Struggling?

                                                • National brands losing shares in MULO to value brands
                                                • What’s Next?

                                                  • “Smart” products and digital innovations are changing diabetes care
                                                    • Longer-term implantable CGMs
                                                      • Skin patches and tattoos may offer non-invasive glucose monitoring options
                                                        • Smart contact lenses may help monitor glucose
                                                          • Wearable tooth sensors may measure intake of sugar, salt, and alcohol
                                                            • Smart footwear for diabetics to offer better support and biometric feedback
                                                              • DNA testing and stem cell therapies in development
                                                              • The Consumer – What You Need to Know

                                                                • Over half of diabetics are exercising and seeking to lose weight
                                                                  • Prescription medication and glucose monitoring widely used tools
                                                                    • Use of monitors and insulin highest for type 1 diabetics
                                                                      • Healthcare professionals are top source of guidance
                                                                        • Overall barriers to management are limited; but spike among type 1 diabetics
                                                                          • Awareness of healthy lifestyle benefits and interest in screening
                                                                          • Lifestyle Management

                                                                            • Over half of diabetics are exercising and seeking to lose weight
                                                                                • Figure 20: Lifestyle management, May 2018
                                                                              • Majority undertake multiple activities to address diabetes
                                                                                • Figure 21: Repertoire of lifestyle management, May 2018
                                                                              • Weight loss less salient for type I diabetes, but key priority of others
                                                                                • Figure 22: Lifestyle management activities, by diabetes type, May 2018
                                                                              • Type 1 diabetics use the greatest number of diabetic specific products
                                                                                • Figure 23: Diabetes specific products actively used, by diabetes type, May 2018
                                                                            • Medical Management

                                                                              • Prescription medication and glucose monitoring widely used tools
                                                                                • Figure 24: Medical management of diabetes, May 2018
                                                                              • Type 2 diabetics have a strong reliance on prescription medication
                                                                                • Figure 25: Any current usage of prescription medication or vitamins, minerals, and supplements, by diabetes type, May 2018
                                                                              • Type 1 diabetics rely most on insulin therapy
                                                                                • Figure 26: Any current use of insulin injections or artificial pancreas, by diabetes type, May 2018
                                                                              • Monitoring devices are essential; type used differ by diabetes type
                                                                                • Figure 27: Any current usage of monitoring devices, by type of diabetes, May 2018
                                                                              • Usage of lancets, testing strips, and control dovetails with monitor usage
                                                                                • Figure 28: Any current usage of secondary products used to monitor blood sugar, by type of diabetes, May 2018
                                                                              • Range of diabetics interested in offerings that streamline treatment
                                                                                • Figure 29: Interest in trying CGM that requires no finger-stick and closed loop system, by type of diabetes, May 2018
                                                                            • Sources for Diabetes Guidance

                                                                              • A serious condition requires professional guidance
                                                                                • Figure 30: Sources for diabetes information, May 2018
                                                                              • Type 1 diabetics turn to specialists, type 2/prediabetes to generalists
                                                                                • Figure 31: Healthcare professsionals used for diabetes information, by type of diabetes, May 2018
                                                                              • Type 1 and prediabetics’ online engagement stands out
                                                                                • Figure 32: Other sources for diabetes information, by diabetes type, May 2018
                                                                            • Barriers to Care

                                                                              • Barriers to managing diabetes are somewhat limited
                                                                                • Figure 33: Barriers to care, May 2018
                                                                              • Type 1 diabetics do note more significant barriers to care
                                                                                • Figure 34: Find care costly or overwhelming, by diabetes type, May 2018
                                                                            • General Attitudes toward Diabetes

                                                                              • US adults recognize diet, exercise, screening can help prevent diabetes
                                                                                • Figure 35: General attitudes toward diabetes, May 2018
                                                                              • Adults living with diabetes sensitive to relentless traits of diabetes
                                                                                • Figure 36: Select attitudes toward diabetes, by diabetes type, May 2018
                                                                              • Those with diabetes worried about passing on to children
                                                                                • Figure 37: Worries about developing or passing on diabetes, by diabetes type, May 2018
                                                                              • Prediabetics most in favour of regular screening
                                                                                • Figure 38: Attitudes toward preventive measures and treatment, by adults diagnosed with diabetes or pre-diabetes, May 2018
                                                                            • Appendix – Data Sources and Abbreviations

                                                                              • Data sources
                                                                                • Sales data
                                                                                  • Consumer survey data
                                                                                    • Abbreviations and terms
                                                                                      • Abbreviations
                                                                                      • Appendix – Key Players

                                                                                          • Figure 39: Multi-outlet sales of OTC glucose monitors, by leading companies, rolling 52 weeks 2017 and 2018
                                                                                          • Figure 40: Multi-outlet sales of lancets/devices, by leading companies, rolling 52 weeks 2017 and 2018
                                                                                          • Figure 41: Multi-outlet sales of other home testing kits and accessories, by leading companies, rolling 52 weeks 2017 and 2018

                                                                                      Diabetic Health - US - September 2018

                                                                                      US $4,395.00 (Excl.Tax)